Sign In
Buy BNTX
$89.59
+1.14 (+1.29%)
At Close: Jun 04, 2026
3 Top Healthcare Stocks to Buy for April
06:50am, Sunday, 10'th Apr 2022
When good companies are out of favor is often the best time to buy.
3 Breakout Growth Stocks to Buy for the Long Haul
10:11am, Saturday, 09'th Apr 2022 The Motley Fool
Investors who can look over the horizon could realize outsize gains.
3 Breakout Growth Stocks to Buy for the Long Haul
06:11am, Saturday, 09'th Apr 2022
Investors who can look over the horizon could realize outsize gains.
BioNTech SE Sponsored ADR (BNTX) Gains As Market Dips: What You Should Know
09:50pm, Friday, 08'th Apr 2022 Zacks Investment Research
In the latest trading session, BioNTech SE Sponsored ADR (BNTX) closed at $170.26, marking a +0.68% move from the previous day.
Why Novavax Stock Dropped 23.6% This Week
04:20pm, Friday, 08'th Apr 2022 The Motley Fool
The company is still waiting for the FDA to give Emergency Use Authorization for its COVID-19 vaccine.
Centennial Resource Development and ShotSpotter have been highlighted as Zacks Bull and Bear of the Day
02:41pm, Friday, 08'th Apr 2022 Zacks Investment Research
Centennial Resource Development and ShotSpotter are part of Zacks Bull and Bear of the Day article.
BioNTech erhält Auftrag im Rahmen des Pandemiebereitschaftsvertrags vom Bundesministerium für Gesundheit der Bundesrepublik Deutschland
01:25pm, Friday, 08'th Apr 2022 GlobeNewswire Inc.
MAINZ, Deutschland, 08. April 2022 — BioNTech SE (Nasdaq: BNTX) gab heute bekannt, dass das Unternehmen eines der von der Bundesrepublik Deutschland ausgewählten Unternehmen ist, mit dem ein Pandem
BioNTech Granted Pandemic Preparedness Contract by German Federal Ministry of Health
01:25pm, Friday, 08'th Apr 2022 GlobeNewswire Inc.
MAINZ, Germany, April 8, 2022 — BioNTech SE (Nasdaq: BNTX) today announced that it is one of the companies in Germany to be granted a pandemic preparedness contract by the Federal Republic of German
BioNTech: Buy The Dip
05:10am, Friday, 08'th Apr 2022
I estimate BioNTech is worth $265 per share, implying a 57% upside potential. BioNTech and Pfizer signed orders to deliver 2.4 billion COVID-19 vaccine doses in 2022. I predict there will be more orde
EU Agencies Doubtful About Need for 2nd COVID Booster
01:26pm, Thursday, 07'th Apr 2022 Zacks Investment Research
The European health agencies agreed that the fourth dose of mRNA-based COVID-19 vaccines of Pfizer (PFE)/BioNTech (BNTX) and Moderna (MRNA) may be given to adults 80 years and above.
BA.2 subvariant of omicron accounted for almost 94% of global cases in latest week, the latest sign of how dominant it has become
11:57am, Thursday, 07'th Apr 2022 MarketWatch
The omicron variant of the coronavirus that causes COVID-19 accounted for 99.8% of global new cases in the latest week, the World Health Organization said Wednesday, and the BA.2 subvariant accounted
EU Agencies Doubtful About Need for 2nd COVID Booster
10:32am, Thursday, 07'th Apr 2022
The European health agencies agreed that the fourth dose of mRNA-based COVID-19 vaccines of Pfizer (PFE)/BioNTech (BNTX) and Moderna (MRNA) may be given to adults 80 years and above.
Forget Robinhood and Buy These 2 Growth Stocks Instead
03:00pm, Wednesday, 06'th Apr 2022 The Motley Fool
These shares have underperformed the market in the past year, but they could be winners over the long term.
Pfizer/BioNTech's Second COVID-19 Vaccine Booster Provides Short-Lived Protection In Elderly, Israel Study Shows
02:26pm, Wednesday, 06'th Apr 2022
An Israel-based study has found that a fourth dose of the Pfizer Inc (NYSE: PFE) / BioNTech SE (NASDAQ: BNTX) vaccine lowered rates of COVID-19 infection among the elderly. However, the protectio
1 Red Flag and 1 Green Flag for Pfizer
12:00pm, Wednesday, 06'th Apr 2022 The Motley Fool
Should we worry about a decline in vaccine revenue?
